| Literature DB >> 32132964 |
Jennifer Kornelsen1,2, Alyssia Wilson3, Jennifer S Labus4, Kelcie Witges2, Emeran A Mayer4, Charles N Bernstein2,3.
Abstract
Inflammatory bowel disease (IBD) is a chronic disease that is associated with aspects of brain anatomy and activity. In this preliminary MRI study, we investigated differences in brain structure and in functional connectivity (FC) of brain regions in 35 participants with Crohn's disease (CD) and 21 healthy controls (HC). Voxel-based morphometry (VBM) analysis was performed to contrast CD and HC structural images. Region of interest (ROI) analyses were run to assess FC for resting-state network nodes. Independent component analysis (ICA) identified whole brain differences in FC associated with resting-state networks. Though no structural differences were found, ROI analyses showed increased FC between the frontoparietal (FP) network and salience network (SN), and decreased FC between nodes of the default mode network (DMN). ICA results revealed changes involving cerebellar (CER), visual (VIS), and SN components. Differences in FC associated with sex were observed for both ROI analysis and ICA. Taken together, these changes are consistent with an influence of CD on the brain and serve to direct future research hypotheses.Entities:
Keywords: Crohn's disease (CD); functional connectivity (FC); functional magnetic resonance imaging (fMRI); inflammatory bowel disease (IBD); resting-state networks (RSNs)
Year: 2020 PMID: 32132964 PMCID: PMC7040490 DOI: 10.3389/fneur.2020.00048
Source DB: PubMed Journal: Front Neurol ISSN: 1664-2295 Impact factor: 4.003
Demographics and relevant clinical data for all subjects.
| Sex (male/female) | 18/17 | 14/7 | 0.273 |
| Age (years) | 32.6 ± 11.4 | 26.9 ± 10.0 | 0.066 |
| BMI | 27.1 ± 4.4 | 25.5 ± 4.9 | 0.801 |
| Harvey–Bradshaw (active/inactive) | 7/28 | – | – |
| Bowel habits (normal/abnormal) | 14/21 | 21/0 | <0.001 |
| Disease duration (years) | 11.3 ± 7.1 | – | – |
| Montreal classification | |||
| Location | |||
| L1 | 18 | ||
| L2 | 3 | – | – |
| L3 | 13 | – | – |
| L4* | 3 | – | – |
| Behavior | |||
| B1 | 20 | – | – |
| B2 | 7 | – | – |
| B3 | 10 | – | – |
| P | 5 | – | – |
| IBD medications (biologics/no biologics) | 13/22 | – | – |
Values for age, BMI, and disease duration are presented as mean values and standard deviations. Values for sex, bowel habits, Harvey–Bradshaw, Montreal classification, and IBD medications are presented as number of subjects in that category. BMI, body mass index; L1, ileum; L2, colonic; L3, ileocolonic; L4.
ROI-to-ROI results showing functional connectivity differences between Crohn's disease patients and healthy controls (CD > HC) controlling for age, sex, BMI, and acquisition site followed by results of contrast between patient females and healthy females (CDF > HCF) controlling for age, BMI, and acquisition site (threshold ROI-to-ROI connections by intensity, FDR p < 0.05, two-sided).
| Lateral pre-frontal cortex R | Supramarginal gyrus L | 3.53 | 0.019 | 0.07 | −0.10 |
| Supramarginal gyrus R | 3.43 | 0.019 | 0.10 | −0.11 | |
| Supramarginal gyrus L | Lateral pre-frontal cortex R | 3.53 | 0.028 | 0.07 | −0.10 |
| Supramarginal gyrus R | Lateral pre-frontal cortex R | 3.43 | 0.038 | 0.10 | −0.11 |
| Medial pre-frontal cortex | Lateral parietal L | −3.93 | 0.008 | 0.19 | 0.39 |
| Lateral parietal L | Medial pre-frontal cortex | −3.93 | 0.008 | 0.19 | 0.39 |
| Anterior insula L | Lateral pre-frontal cortex L | 3.01 | 0.004 | 0.07 | −0.03 |
| Lateral pre-frontal cortex R | 3.03 | 0.004 | 0.00 | −0.13 | |
| Posterior parietal cortex L | 3.23 | 0.017 | 0.00 | −0.07 | |
| Posterior parietal cortex R | 3.52 | 0.001 | 0.06 | −0.05 | |
| Visual medial | −3.81 | 0.001 | −0.14 | −0.05 | |
| Visual occipital | Supramarginal gyrus R | −4.69 | 0.001 | −0.11 | −0.07 |
| Superior temporal R | −3.51 | 0.015 | −0.06 | 0.05 | |
| Supramarginal gyrus R | Visual occipital | −4.69 | 0.001 | −0.11 | −0.07 |
| Visual medial | −3.20 | 0.036 | −0.12 | −0.04 | |
| Visual medial | Anterior insula L | −3.81 | 0.012 | −0.14 | −0.05 |
| Anterior insula R | −3.57 | 0.012 | −0.10 | −0.05 | |
| Supramarginal gyrus R | −3.20 | 0.024 | −0.12 | −0.04 | |
| Anterior insula R | Visual medial | −3.57 | 0.025 | −0.10 | −0.05 |
| Superior temporal R | Visual occipital | −3.51 | 0.029 | −0.06 | 0.05 |
CD, Crohn's disease; HC, healthy control; CDF, Crohn's disease female; HCF, healthy control female; t, t-value; p, p-value; r CD, mean bivariate correlation for CD group; r HC, mean bivariate correlation for HC group; R, right; L, left; FP, frontoparietal network; SN, salience network; DMN, default mode network; LAN, language network, VIS, visual network.
Figure 1(A) Graphic of ROI-to-ROI contrast showing nodes with increased FC (red) and decreased FC (blue) for the CD group as compared to HCs. (B) Graphic of ROI-to-ROI contrast showing nodes with increased FC (red), decreased FC (blue), and both increased and decreased FC (yellow) for the CD females as compared to the HC females. Both graphics are displayed in axial orientation with the anterior aspect toward the top and right on the right, with ROI-to-ROI connection threshold set by intensity at FDR p < 0.05, two-sided (MPFC, medial pre-frontal cortex; LPFC, lateral pre-frontal cortex; SMG, supramarginal gyrus; LP, lateral parietal; AI, anterior insula; PPC, posterior parietal cortex; STG, superior temporal gyrus).
Differences in FC between Crohn's disease patients and healthy controls (CD > HC) controlling for age, sex, BMI, and acquisition site, and between CD and HC females (CDF > HCF), and CD and HC males (CDM > HCM) controlling for age, BMI, and acquisition site (T threshold = 3.5, uncorrected height threshold p < 0.001, FDR-corrected cluster threshold p < 0.05).
| CER | Superior lateral occipital L | 137 | −46 | −68 | 22 | −5.75 | 0.005 | −0.53 | 0.81 |
| VIS | Putamen L | 97 | −30 | 00 | −8 | 5.43 | 0.029 | 0.77 | −0.70 |
| Occipital pole R | 126 | 18 | −82 | 14 | 4.91 | 0.007 | 1.40 | −0.57 | |
| SN | Planum temporale L | 113 | −46 | −30 | 12 | −4.96 | 0.020 | −0.34 | 1.36 |
| DMN | Temporal pole R | 89 | 32 | 8 | −24 | 4.64 | 0.038 | 0.55 | −2.76 |
| Insula L | 103 | −28 | −24 | 26 | −7.25 | 0.038 | −0.80 | 2.70 | |
| SMN | Orbital frontal cortex L | 135 | −8 | 14 | −26 | 5.42 | 0.012 | 0.92 | −2.94 |
| VIS | Fusiform cortex R | 124 | 36 | −54 | −22 | −5.38 | 0.011 | −0.48 | 1.03 |
| DMN | Angular gyrus R | 106 | 56 | −56 | 16 | −5.72 | 0.025 | 1.18 | 3.40 |
The number of voxels per cluster, MNI coordinates of the peak intensity voxel per cluster, t, p, and mean values are given.
CD, Crohn's disease; HC, healthy control; CDF, Crohn's disease female; HCF, healthy control female; CDM, Crohn's disease male; HCM, healthy control male; R, right; L, left; CER, cerebellar network; VIS, visual network; SN, salience network; DMN, default mode network; SMN, sensorimotor network.
Figure 2ICA contrast between CD > HC for (A) the cerebellar network FC with left superior lateral occipital, (B) the visual network FC with left putamen and (C) the right occipital pole, and (D) the salience network FC with the left planum temporale. The female CD > HC contrast revealed altered FC in the (E) DMN with the right temporal pole and (F) left insula, (G) the SMN with left orbitofrontal cortex, and (H) the visual network with the fusiform gyrus, whereas the male CD > HC contrast showed altered FC of (I) the DMN with the right angular gyrus. All slices correspond to the peak activation coordinates with the color bar representing positive t-values in orange and negative t-values in blue. Slices are shown in neurological orientation (left hemisphere on the left of each slice, anterior toward the top of each slice) and are displayed at T threshold = 3.5, uncorrected height threshold p < 0.001, and FDR-corrected cluster threshold p < 0.05.